Big Gain For Genprex, Inc.
Mon, Oct 21, 2024 at 07:44 PM
Genprex, Inc. (GNPX:NASDAQ) shot up at $1.51, representing a gain of 260.4%. On Mon, Oct 21, 2024, GNPX:NASDAQ hit a New 2-Week High of $1.51. The stock got featured on our News Catalysts scanner on Wed, Oct 16, 2024 at 10:43 AM in the 'BIOTECH' category. From Mon, Oct 07, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Oct 21, 2024 at $2.04 with a volume of 275M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Genprex, Inc. (GNPX:NASDAQ), 260.38%
- GRI Bio Inc Com (GRI:NASDAQ), 127.59%
- Siyata Mobile Inc. (SYTA:NASDAQ), 82.18%
- Sensei Biotherapeutics Inc. (SNSE:NASDAQ), 78.08%
- IN8bio Inc. (INAB:NASDAQ), 75.28%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 55.94%
- Spirit Airlines, Inc. (SAVE:NYSE), 53.06%
- Neo-Concept International Group Holdings Limited (NCI:NASDAQ), 48.57%
- Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 47.18%
- Histogen Inc. (HSTO:NASDAQ), 41.18%